Yin Tinggui - Lilly Res Labs, Eli Lilly & Co

基本信息

浏览量：28

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 38 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 1968: Discovery of a Highly Potent and Selective FGFR2 Inhibitor for FGFR2-driven Cancers

Wenqian Li, Bin Liu, Junmei Wang,Tinggui Yin,Kuo-Long Yu, Sanjeev Kumar,Zhiming Wen,Genshi Zhao,Weitao Pan

Cancer Researchno. 6_Supplement (2024): 1968-1968

引用0浏览0引用

Abstract 5947: Discovery of ACE-47228211, a Highly Potent and Selective SOS1 Inhibitor

Junmei Wang, Wenqian Li, Sanjeev Kumar,Weitao Pan,Zhiming Wen,Tinggui Yin,Genshi Zhao,Kuo-Long Yu

Cancer Researchno. 6_Supplement (2024): 5947-5947

引用0浏览0引用

Abstract 4525: Discovery of a Highly Potent and Selective PARP1 Inhibitor with Superior PK and Safety Profiles

Yi Wei, Wenming Li, Zehui Li, Manhua Li, Kai Kang,Zhiming Wen,Tinggui Yin,Kuo-Long Yu,Genshi Zhao, Hongbin Yuan

Cancer Researchno. 6_Supplement (2024): 4525-4525

引用0浏览0引用

Abstract 1961: Discovery of a Highly Potent and Brain Penetrant Fourth Generation EGFR Tyrosine Kinase Inhibitor

Sanjeev Kumar, Junmei Wang, Wenqian Li,Weitao Pan,Zhiming Wen,Kuo-Long yu,Genshi Zhao,Tinggui Yin

Cancer Researchno. 6_Supplement (2024): 1961-1961

引用0浏览0引用

Supplementary Figures 1 and 2 and Supplementary Tables 1 Through 3 from A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

Tinggui Yin,Marı́a José Lallena,Emiko L. Kreklau,Kevin R. Fales, Santiago Carballares,Raquel Torrres,Graham N. Wishart,Rose T. Ajamie,Damien M. Cronier,Phillip W. Iversen, Timothy I. Meier,Robert T. Foreman,Douglas J. Zeckner,Sean E. Sissons, Bart W. Halstead,Aimee Bence Lin,Gregory P. Donoho,Yuewei Qian, Shuyu Li, Song Wu,Amit Aggarwal,Xiang S. Ye,James J. Starling, Richard B. Gaynor,Alfonso De Dios, Jie Du

openalex（2023）

引用0浏览0引用

Supplementary Figures S1 - S7, Tables S1 - S2 from Oncogenic <i>braf</i> Deletions That Function As Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120

Shih-Hsun Chen,Youyan Zhang,Robert D. Van Horn,Tinggui Yin,Sean G. Buchanan,Vipin K. Yadav,Igor Mochalkin, Suei Nee Wong,Yong Yue,Lysiane Huber,Ilaria Conti,James R. Henry,James J. Starling, Gregory D. Plowman,Sheng-Bin Peng

openalex（2023）

引用0浏览0引用

Supplementary Information from A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models

Xiang S. Ye,Li Fan,Robert D. Van Horn,Ryuichiro Nakai,Yoshihisa Ohta,Shiro Akinaga,Chikara Murakata,Yoshinori Yamashita,Tinggui Yin,Kelly M. Credille,Gregory P. Donoho,Farhana F. Merzoug,Heng Li,Amit Aggarwal,Kerry Blanchard,Eric H. Westin

openalex（2023）

引用0浏览0引用

Data from Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120

Shih-Hsun Chen,Youyan Zhang,Robert D. Van Horn,Tinggui Yin,Sean Buchanan,Vipin Yadav,Igor Mochalkin,Swee Seong Wong,Yong Gang Yue,Lysiane Huber,Ilaria Conti,James R. Henry,James J. Starling,Gregory D. Plowman,Sheng-Bin Peng

crossref（2023）

引用0浏览0引用

Supplementary Tables 1-2 from A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models

Xiang S. Ye, Li Fan,Robert D. Van Horn,Ryuichiro Nakai,Yoshihisa Ohta,Shiro Akinaga,Chikara Murakata,Yoshinori Yamashita,Tinggui Yin,Kelly M. Credille,Gregory P. Donoho,Farhana F. Merzoug, Heng Li,Amit Aggarwal,Kerry Blanchard,Eric H. Westin

crossref（2023）

引用0浏览0引用

A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

semanticscholar（2023）

引用79浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn